Media Advisory - IndyCar Racer Charlie Kimball
doesn't let his diabetes take the driver's seat Read More
Important safety information regarding NovoPen Echo® and NovoPen® 5. Read More
New fast-acting mealtime insulin, Fiasp®, now approved and available in Canada for the treatment of diabetes... Read More
Press releases from the Denmark headquarters.
Visit the pressroom of the website for our headquarters in Denmark where you can access the latest corporate stock exchange announcements, an image library, interim and annual reports and other relevant communication from Novo Nordisk A/S.